Uncovering the role of tumor cGAS expression in predicting response to PD-1/L1 inhibitors in non-small cell lung cancer
Abstract Objectives The impact of cGAS/STING tumor expression on PD-1/L1 inhibitor efficacy and the tumor microenvironment remain to be elucidated. Methods In a post-hoc analysis of a prospective biomarker study with 106 advanced NSCLC patients treated with PD-1/L1 inhibitors from December 2015 to S...
Saved in:
Main Authors: | Yuichi Ozawa, Yasuhiro Koh, Ryota Shibaki, Yuhei Harutani, Hiroaki Akamatsu, Atsushi Hayata, Takeya Sugimoto, Yuka Kitamura, Junya Fukuoka, Masanori Nakanishi, Nobuyuki Yamamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-11-01
|
Series: | Cancer Immunology, Immunotherapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00262-024-03861-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
cGAS-STING targeting offers therapy choice in lung diseases
by: Yu Wang, et al.
Published: (2025-02-01) -
MVK, induced by Kras, represses cGAS-Sting signalling in lung adenocarcinoma
by: Changsheng Zhou, et al.
Published: (2025-01-01) -
Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics
by: BingBing Li, et al.
Published: (2025-02-01) -
C9orf72 Alleviates DSS‑Induced Ulcerative Colitis via the cGAS‐STING Pathway
by: Yue Wang, et al.
Published: (2025-01-01) -
Editorial: Activation of the cGAS-STING pathway by extra-nuclear DNA and its pharmacognostic modulation in human disease
by: Preston M. McCourt, et al.
Published: (2025-01-01)